Cargando…
Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis
BACKGROUND & AIMS: Bcl-xL, an anti-apoptotic Bcl-2 family protein, is overexpressed in 90% of pancreatic ductal adenocarcinoma (PDAC) cases. However, Bcl-xL expression in pancreatic intraepithelial neoplasias (PanINs) and its significance in PDAC carcinogenesis remain unclear. The aim of this st...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604117/ https://www.ncbi.nlm.nih.gov/pubmed/28948203 http://dx.doi.org/10.1016/j.jcmgh.2017.02.001 |
_version_ | 1783264812662259712 |
---|---|
author | Ikezawa, Kenji Hikita, Hayato Shigekawa, Minoru Iwahashi, Kiyoshi Eguchi, Hidetoshi Sakamori, Ryotaro Tatsumi, Tomohide Takehara, Tetsuo |
author_facet | Ikezawa, Kenji Hikita, Hayato Shigekawa, Minoru Iwahashi, Kiyoshi Eguchi, Hidetoshi Sakamori, Ryotaro Tatsumi, Tomohide Takehara, Tetsuo |
author_sort | Ikezawa, Kenji |
collection | PubMed |
description | BACKGROUND & AIMS: Bcl-xL, an anti-apoptotic Bcl-2 family protein, is overexpressed in 90% of pancreatic ductal adenocarcinoma (PDAC) cases. However, Bcl-xL expression in pancreatic intraepithelial neoplasias (PanINs) and its significance in PDAC carcinogenesis remain unclear. The aim of this study was to elucidate the significance of Bcl-xL expression in PanINs. METHODS: We investigated the expression levels of Bcl-xL in pancreas-specific KrasG12D (P-KrasG12D) mice and human PanINs and PDAC. We examined the impact of Bcl-xL expression on Kras-mutated pancreatic neoplasia using Bcl-xL–overexpressing P-KrasG12D mice and Bcl-xL–knockout P-KrasG12D mice. RESULTS: In P-KrasG12D mice, the number of PanINs increased and their grades progressed with age. In total, 55.6% of these mice developed PDAC at 12–14 months. According to the immunohistochemistry of mouse pancreas and human resected specimens, Bcl-xL expression was increased significantly in PanIN-1 compared with that in normal pancreatic ducts, and augmented further with the progression of pancreatic neoplasia in PanIN-2/3 and PDAC. Oncogene-induced senescence was observed frequently in PanIN-1, but rarely was detected in PanIN-2/3 and PDAC. Bcl-xL overexpression significantly accelerated the progression to high-grade PanINs and PDAC and reduced the survival of P-KrasG12D mice. Bcl-xL overexpression in P-KrasG12D mice suppressed oncogene-induced senescence in PanIN-1 and inhibited apoptosis in PanIN-3. Bcl-xL deficiency in P-KrasG12D mice induced cellular senescence in PanIN-2/3. CONCLUSIONS: Bcl-xL expression increases with the progression from PanIN-1 to PDAC, whereas oncogene-induced senescence decreases. Bcl-xL overexpression increases PDAC incidence rates by inhibiting oncogene-induced senescence and apoptosis in PanINs. Conversely, Bcl-xL deficiency induced senescence in PanINs. Anti–Bcl-xL treatments may have the potency to suppress the progression from PanINs to PDAC. |
format | Online Article Text |
id | pubmed-5604117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-56041172017-09-25 Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis Ikezawa, Kenji Hikita, Hayato Shigekawa, Minoru Iwahashi, Kiyoshi Eguchi, Hidetoshi Sakamori, Ryotaro Tatsumi, Tomohide Takehara, Tetsuo Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: Bcl-xL, an anti-apoptotic Bcl-2 family protein, is overexpressed in 90% of pancreatic ductal adenocarcinoma (PDAC) cases. However, Bcl-xL expression in pancreatic intraepithelial neoplasias (PanINs) and its significance in PDAC carcinogenesis remain unclear. The aim of this study was to elucidate the significance of Bcl-xL expression in PanINs. METHODS: We investigated the expression levels of Bcl-xL in pancreas-specific KrasG12D (P-KrasG12D) mice and human PanINs and PDAC. We examined the impact of Bcl-xL expression on Kras-mutated pancreatic neoplasia using Bcl-xL–overexpressing P-KrasG12D mice and Bcl-xL–knockout P-KrasG12D mice. RESULTS: In P-KrasG12D mice, the number of PanINs increased and their grades progressed with age. In total, 55.6% of these mice developed PDAC at 12–14 months. According to the immunohistochemistry of mouse pancreas and human resected specimens, Bcl-xL expression was increased significantly in PanIN-1 compared with that in normal pancreatic ducts, and augmented further with the progression of pancreatic neoplasia in PanIN-2/3 and PDAC. Oncogene-induced senescence was observed frequently in PanIN-1, but rarely was detected in PanIN-2/3 and PDAC. Bcl-xL overexpression significantly accelerated the progression to high-grade PanINs and PDAC and reduced the survival of P-KrasG12D mice. Bcl-xL overexpression in P-KrasG12D mice suppressed oncogene-induced senescence in PanIN-1 and inhibited apoptosis in PanIN-3. Bcl-xL deficiency in P-KrasG12D mice induced cellular senescence in PanIN-2/3. CONCLUSIONS: Bcl-xL expression increases with the progression from PanIN-1 to PDAC, whereas oncogene-induced senescence decreases. Bcl-xL overexpression increases PDAC incidence rates by inhibiting oncogene-induced senescence and apoptosis in PanINs. Conversely, Bcl-xL deficiency induced senescence in PanINs. Anti–Bcl-xL treatments may have the potency to suppress the progression from PanINs to PDAC. Elsevier 2017-02-20 /pmc/articles/PMC5604117/ /pubmed/28948203 http://dx.doi.org/10.1016/j.jcmgh.2017.02.001 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Ikezawa, Kenji Hikita, Hayato Shigekawa, Minoru Iwahashi, Kiyoshi Eguchi, Hidetoshi Sakamori, Ryotaro Tatsumi, Tomohide Takehara, Tetsuo Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis |
title | Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis |
title_full | Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis |
title_fullStr | Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis |
title_full_unstemmed | Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis |
title_short | Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis |
title_sort | increased bcl-xl expression in pancreatic neoplasia promotes carcinogenesis by inhibiting senescence and apoptosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604117/ https://www.ncbi.nlm.nih.gov/pubmed/28948203 http://dx.doi.org/10.1016/j.jcmgh.2017.02.001 |
work_keys_str_mv | AT ikezawakenji increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis AT hikitahayato increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis AT shigekawaminoru increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis AT iwahashikiyoshi increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis AT eguchihidetoshi increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis AT sakamoriryotaro increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis AT tatsumitomohide increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis AT takeharatetsuo increasedbclxlexpressioninpancreaticneoplasiapromotescarcinogenesisbyinhibitingsenescenceandapoptosis |